athenahealth, Inc. (ATHN) Given Consensus Recommendation of “Hold” by Brokerages

Shares of athenahealth, Inc. (NASDAQ:ATHN) have been assigned an average rating of “Hold” from the twenty-eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $143.00.

A number of research firms have recently commented on ATHN. Oppenheimer Holdings, Inc. reiterated a “buy” rating and issued a $184.00 price objective on shares of athenahealth in a report on Friday, October 20th. Piper Jaffray Companies reiterated a “buy” rating and issued a $167.00 price objective on shares of athenahealth in a report on Tuesday, October 17th. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $156.00 price objective on shares of athenahealth in a report on Wednesday, October 25th. Jefferies Group LLC set a $110.00 price objective on athenahealth and gave the company a “hold” rating in a report on Friday, October 13th. Finally, Leerink Swann set a $155.00 price objective on athenahealth and gave the company a “hold” rating in a report on Thursday, October 19th.

In related news, SVP Bradford Kyle Armbrester sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, October 27th. The stock was sold at an average price of $128.56, for a total transaction of $128,560.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Brandon H. Hull sold 800 shares of the stock in a transaction that occurred on Monday, November 20th. The stock was sold at an average price of $130.00, for a total value of $104,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 13,283 shares of company stock worth $1,741,372 in the last 90 days. 3.20% of the stock is currently owned by company insiders.

A number of institutional investors have recently bought and sold shares of the business. Pura Vida Investments LLC lifted its position in athenahealth by 39.1% during the 3rd quarter. Pura Vida Investments LLC now owns 59,800 shares of the health services provider’s stock worth $7,437,000 after acquiring an additional 16,800 shares during the period. California Public Employees Retirement System lifted its position in athenahealth by 1.6% during the 3rd quarter. California Public Employees Retirement System now owns 75,000 shares of the health services provider’s stock worth $9,327,000 after acquiring an additional 1,200 shares during the period. Perceptive Advisors LLC acquired a new stake in athenahealth during the 3rd quarter worth approximately $8,705,000. Oppenheimer Asset Management Inc. lifted its position in athenahealth by 2.4% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 31,974 shares of the health services provider’s stock worth $3,977,000 after acquiring an additional 737 shares during the period. Finally, Jackson Square Partners LLC lifted its position in athenahealth by 55.4% during the 3rd quarter. Jackson Square Partners LLC now owns 525,738 shares of the health services provider’s stock worth $65,380,000 after acquiring an additional 187,491 shares during the period.

athenahealth (ATHN) traded up $0.15 during mid-day trading on Monday, reaching $129.59. The company’s stock had a trading volume of 22,380 shares, compared to its average volume of 579,395. The company has a quick ratio of 1.67, a current ratio of 1.67 and a debt-to-equity ratio of 0.35. The firm has a market cap of $5,180.00, a price-to-earnings ratio of 109.69, a P/E/G ratio of 5.01 and a beta of 1.57. athenahealth has a 52 week low of $90.11 and a 52 week high of $158.66.

athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.06. The company had revenue of $304.60 million for the quarter, compared to analyst estimates of $310.52 million. athenahealth had a return on equity of 6.78% and a net margin of 2.65%. athenahealth’s revenue for the quarter was up 10.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.60 EPS. equities analysts anticipate that athenahealth will post 1.16 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece of content on another site, it was illegally copied and reposted in violation of US & international copyright & trademark laws. The correct version of this piece of content can be viewed at https://transcriptdaily.com/2017/11/27/athenahealth-inc-athn-given-consensus-recommendation-of-hold-by-brokerages.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply